Vanguard Group Inc Myriad Genetics Inc Transaction History

Vanguard Group Inc

  • $6.44 Trillion
  • Q3 2025

A detailed history of Vanguard Group Inc transactions in Myriad Genetics Inc stock. As of the latest transaction made, Vanguard Group Inc holds 7,882,515 shares of MYGN stock, worth $52.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,882,515
Previous 9,257,493 14.85%
Holding current value
$52.9 Million
Previous $49.2 Million 15.93%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
SELL
$3.84 - $7.84 $5.28 Million - $10.8 Million
-1,374,978 Reduced 14.85%
7,882,515 $57 Million
Q2 2025

Aug 11, 2025
SELL
$3.84 - $8.84 $5.42 Million - $12.5 Million
-1,410,262 Reduced 13.22%
9,257,493 $49.2 Million
Q1 2025

May 09, 2025
BUY
$8.87 - $14.98 $680,435 - $1.15 Million
76,712 Added 0.72%
10,667,755 $94.6 Million
Q4 2024

Feb 11, 2025
BUY
$13.17 - $27.03 $3.68 Million - $7.55 Million
279,379 Added 2.71%
10,591,043 $145 Million
Q3 2024

Nov 13, 2024
BUY
$23.97 - $28.6 $5.92 Million - $7.06 Million
246,993 Added 2.45%
10,311,664 $282 Million
Q2 2024

Aug 13, 2024
BUY
$17.98 - $25.47 $520,754 - $737,687
28,963 Added 0.29%
10,064,671 $246 Million
Q1 2024

May 10, 2024
BUY
$17.59 - $23.59 $1.43 Million - $1.92 Million
81,475 Added 0.82%
10,035,708 $214 Million
Q4 2023

Feb 14, 2024
BUY
$13.91 - $21.32 $11 Million - $16.8 Million
789,496 Added 8.61%
9,954,233 $191 Million
Q3 2023

Nov 14, 2023
BUY
$15.99 - $23.22 $198,116 - $287,695
12,390 Added 0.14%
9,164,737 $147 Million
Q2 2023

Aug 14, 2023
SELL
$17.56 - $23.76 $2.56 Million - $3.47 Million
-146,067 Reduced 1.57%
9,152,347 $212 Million
Q1 2023

May 15, 2023
SELL
$15.26 - $23.75 $203,675 - $316,991
-13,347 Reduced 0.14%
9,298,414 $216 Million
Q4 2022

Feb 10, 2023
BUY
$14.51 - $20.99 $2.66 Million - $3.85 Million
183,377 Added 2.01%
9,311,761 $135 Million
Q3 2022

Nov 14, 2022
BUY
$18.21 - $27.88 $2.22 Million - $3.39 Million
121,704 Added 1.35%
9,128,384 $174 Million
Q2 2022

Aug 12, 2022
BUY
$16.45 - $25.88 $494,931 - $778,651
30,087 Added 0.34%
9,006,680 $164 Million
Q1 2022

May 13, 2022
SELL
$22.67 - $28.01 $3.92 Million - $4.84 Million
-172,928 Reduced 1.89%
8,976,593 $226 Million
Q4 2021

Feb 14, 2022
BUY
$24.13 - $32.63 $2.81 Million - $3.8 Million
116,324 Added 1.29%
9,149,521 $253 Million
Q3 2021

Nov 12, 2021
BUY
$29.97 - $36.66 $2.47 Million - $3.02 Million
82,377 Added 0.92%
9,033,197 $292 Million
Q2 2021

Aug 13, 2021
BUY
$25.39 - $32.61 $227 Million - $292 Million
8,950,820 New
8,950,820 $274 Million

Others Institutions Holding MYGN

# of Institutions
237
Shares Held
92.1M
Call Options Held
86.1K
Put Options Held
18.9K
View Full List

About MYRIAD GENETICS INC

MYGN Quotes by TradingView
  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $541M
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email